Analytical Data
-
Gene name
TKT
- Application
-
Alternative Names
TK; Wernicke-Korsakoff Syndrome
-
Species
Rat
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P50137
-
Expression Region
Met1~Lys286
-
Molecular Weight
35kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TKT, or transketolase, is an essential enzyme involved in the pentose phosphate pathway, which plays a critical role in cellular metabolism and the biosynthesis of nucleotides and amino acids. The study of TKT and its recombinant forms has gained significant attention due to its potential applications in biotechnology and medicine. Researchers have identified that mutations in the TKT gene can lead to various metabolic disorders, highlighting the importance of understanding its structure and function. Recombinant TKT proteins are valuable for biochemical studies, allowing scientists to investigate enzyme kinetics, substrate specificity, and regulatory mechanisms in a controlled environment. Furthermore, the production of TKT in heterologous systems facilitates the exploration of its potential as a therapeutic target for diseases associated with metabolic dysregulation, including cancer and diabetes. By characterizing recombinant TKT proteins, researchers aim to elucidate the enzyme's role in cellular processes, innovate metabolic engineering approaches, and develop novel strategies for disease treatment, underscoring the significance of TKT in both fundamental and applied biological research.
